These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28505278)

  • 1. Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    Vargas-Palacios A; Meads DM; Twiddy M; Czoski Murray C; Hulme C; Mitchell ED; Gregson A; Stanley P; Minton J
    J Antimicrob Chemother; 2017 Aug; 72(8):2392-2400. PubMed ID: 28505278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services.
    Czoski Murray C; Twiddy M; Meads D; Hess S; Wright J; Mitchell ED; Hulme C; Dodd S; Gent H; Gregson A; McLintock K; Raynor DK; Reynard K; Stanley P; Vincent R; Minton J
    BMJ Open; 2015 Aug; 5(8):e008965. PubMed ID: 26297374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cost-effectiveness, safety and acceptability of
    Mitchell ED; Czoski Murray C; Meads D; Minton J; Wright J; Twiddy M
    BMJ Open; 2017 Apr; 7(4):e013560. PubMed ID: 28428184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
    Dimitrova M; Gilchrist M; Seaton RA
    BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy.
    Hersh AL; Olson J; Stockmann C; Thorell EA; Knackstedt ED; Esquibel L; Sanderson S; Pavia AT
    J Pediatric Infect Dis Soc; 2018 May; 7(2):e34-e36. PubMed ID: 28549165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.
    Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA
    J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
    Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
    Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.
    Vaz LE; Farnstrom CL; Felder KK; Guzman-Cottrill J; Rosenberg H; Antonelli RC
    J Pediatric Infect Dis Soc; 2018 May; 7(2):136-142. PubMed ID: 28419343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.
    Fisher D; Michaels J; Hase R; Zhang J; Kataria S; Sim B; Tsang JK; Pollard J; Chan M; Swaminathan S
    J Antimicrob Chemother; 2017 Apr; 72(4):1221-1226. PubMed ID: 28077673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.
    Jensen IS; Wu E; Fan W; Lodise TP; Nicolau DP; Dufour S; Cyr PL; Sulham KA
    J Manag Care Spec Pharm; 2016 Jun; 22(6):752-64. PubMed ID: 27231802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
    Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
    Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.